title: Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
abstract: Based on the powerful virostatic potency and cytostatic activity of adenine, 2,6-diaminopurine, and guanine derivatives of acyclic phosphonate nucleotide analog (S)-1-(3-hydroxy-2-phosphonomethoxypropyl) and 9-(2-phosphonomethoxyethyl) series, we examined the inhibitory potencies of their diphosphates [(S)-9-(3-hydroxy-2-phosphonomethoxypropyl)adenine diphosphate (HPMPApp), 9-(2-phosphonomethoxyethyl)adenine diphosphate, 9-(2-phosphonomethoxyethyl)-2,6-diaminopurine diphosphate (PMEDAPpp), and 9-(2-phosphonomethoxyethyl)guanine diphosphate, analogs of nucleoside 5'-triphosphates] toward cellular DNA polymerases alpha, delta, and epsilon (isolated from tumors of T cell spontaneous acute lymphoblastic leukemia in Sprague-Dawley inbred rats). Kinetic measurements (K(m), K(i), and V(max)) of synthetic homopolymeric template primers have shown that HPMPApp is a selective and potent inhibitor of polymerase epsilon, whereas PMEDAPpp strongly inhibits polymerase delta. These two compounds may be useful for elucidating the roles of polymerases delta and epsilon. Of the nucleotide analogs tested, 9-(2-phosphonomethoxyethyl) guanine diphosphate is the most efficient inhibitor of polymerases alpha and epsilon, whereas the diphosphate of 9-(2-phosphonomethoxyethyl) adenine, the therapeutically important agent adefovir, inhibits polymerases alpha and epsilon relatively poorly and exerts only moderate inhibition of polymerase delta. These data are quite consistent with previously reported cytostatic activity of these nucleotide analogs. All of the enzymes studied catalyze the incorporation of 9-(2-phosphonomethoxyethyl)adenine, 9-(2-phosphonomethoxyethyl)-2, 6-diaminopurine, and (S)-9-(3-hydroxy-2-phosphonomethoxypropyl)adenine into DNA chain. 9-(2-Phosphonomethoxyethyl)adenine diphosphate and PMEDAPpp were confirmed to be DNA chain terminators. On the other hand, HPMPApp formed poly(dT)/oligo(dA(18)-[(S)-9-(3-hydroxy-2-phosphonomethoxypropyl)a denine]2-4 structures.
authors.affiliation: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of The Czech Republic, Prague, The Czech Republic.
authors.forename: P
authors.initials: P
authors.lastname: Kramata
authors.forename: I
authors.initials: I
authors.lastname: Votruba
authors.forename: B
authors.initials: B
authors.lastname: Otová
authors.forename: A
authors.initials: A
authors.lastname: Holý
mesh_terms: D000818:Animals; D004247:DNA / Q000378:metabolism; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors*; D004258:DNA Polymerase III; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007700:Kinetics; D019384:Nucleic Acid Synthesis Inhibitors; D009711:Nucleotides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004791:Enzyme Inhibitors; D019384:Nucleic Acid Synthesis Inhibitors; D009711:Nucleotides; D004247:DNA; D004257:DNA Polymerase II; D004258:DNA Polymerase III